Friday 6 November 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
179.94
2.45
−1.34%
Follow ENSG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
28.99 | 31.83 | 24.40 | 24.87 |
P/S ratio |
1.97 | 2.21 | 1.69 | 1.75 | |
P/FCF ratio |
26.93 | 28.67 | 22.17 | 19.50 | |
P/Operating CF |
54.46 | 116.23 | 54.03 | 41.40 | |
P/B ratio |
4.47 | 4.91 | 3.80 | 3.88 | |
Price to Tangible BV |
4.69 | 5.14 | 3.97 | 4.04 | |
EV/Sales |
1.89 | 2.12 | 1.66 | 1.72 | |
EV/EBITDA |
18.00 | 20.02 | 15.63 | 15.46 | |
EV/Operating CF |
16.93 | 18.89 | 14.97 | 14.02 | |
EV/FCF |
25.77 | 27.55 | 21.74 | 19.13 | |
Quick Ratio |
1.35 | 1.48 | 1.12 | 1.10 | |
Current Ratio |
1.42 | 1.56 | 1.21 | 1.20 | |
Net Debt/EBITDA |
(2.84) | (2.95) | (1.17) | (1.13) | |
Debt/Assets |
2.59% | 2.51% | 2.43% | 3.31% | |
Debt/Equity |
0.06 | 0.06 | 0.06 | 0.08 | |
Asset Turnover |
1.00 | 1.02 | 1.03 | 1.01 | |
Operating CF/Net income |
1.92 | 1.00 | 1.72 | 2.30 | |
Capex/Depreciation |
(1.78) | (1.22) | (1.67) | (1.44) | |
Interest Coverage |
63.33 | 64.62 | 63.38 | 60.36 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.20% | 5.34% | 5.96% | 5.36% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.95% | 1.00% | 1.12% | 1.28% | |
Graham Net Nets |
(0.20) | (0.17) | (0.24) | (0.23) | |
Graham Number |
72.62 | 76.43 | 78.97 | 83.05 | |
Earnings Yield |
3.45% | 3.14% | 4.10% | 4.02% | |
Free Cash Flow Yield |
3.71% | 3.49% | 4.51% | 5.13% | |
Revenue per Share |
23.74 | 24.05 | 24.85 | 25.66 | |
Operating CF per Share |
3.20 | 1.73 | 2.97 | 4.15 | |
Capex per Share |
(0.87) | (0.61) | (0.91) | (0.82) | |
Free Cash Flow per Share |
2.33 | 1.12 | 2.06 | 3.33 | |
Cash per Share |
9.99 | 10.30 | 5.54 | 6.77 | |
Shareholders Equity per Share |
39.00 | 41.02 | 42.19 | 44.33 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
39.00 | 41.02 | 42.19 | 44.33 | |
Free Cash Flow |
133.48 | 64.68 | 119.13 | 192.63 | |
Working Capital |
377.96 | 472.05 | 186.69 | 191.97 | |
Capital Expenditures |
(49.84) | (35.47) | (52.83) | (47.61) | |
Net Current Asset Value |
(1,955.84) | (1,921.96) | (2,232.60) | (2,280.12) | |
EV/EBIT |
22.46 | 24.93 | 19.49 | 19.15 | |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.03 | |
Price to Operating Income |
23.47 | 25.94 | 19.88 | 19.53 | |
| Other line items | |||||
Average Receivables |
603.44 | 623.65 | 623.48 | 638.76 | |
Average Payables |
98.14 | 105.73 | 111.24 | 115.59 | |
Average Assets |
5,066.16 | 5,185.80 | 5,339.84 | 5,612.41 | |
Average Common Equity |
2,037.63 | 2,149.93 | 2,233.15 | 2,343.15 |
Columns are period end dates · fundamentals updated 2 Nov 2026